Restricted accessResearch articleFirst published online 2017-08
Hematopoietic Developmental Potential of Human Pluripotent Stem Cell Lines Is Accompanied by the Morphology of Embryoid Bodies and the Expression of Endodermal and Hematopoietic Markers
The potential clinical applications of hematopoietic stem cells (HSCs) derived from human pluripotent stem cells (hPSCs) are limited by the difficulty of recapitulating embryoid hematopoiesis and by the unknown differentiation potential of hPSC lines. To evaluate their hematopoietic developmental potential, available hPSC lines were differentiated by an embryoid body (EB) suspension culture in serum-free medium supplemented with three different cytokine mixes (CMs). The hPSC differentiation status was investigated by the flow cytometry expression profiles of cell surface molecules, and the gene expression of pluripotency and differentiation markers over time was evaluated by real-time reverse transcription polymerase chain reaction (qRT-PCR). hPSC lines differed in several aspects of the differentiation process, including the absolute yield of hematopoietic progenitors, the proportion of hematopoietic progenitor populations, and the effect of various CMs. The ability to generate hematopoietic progenitors was then associated with the morphology of the developing EBs, the expression of the endodermal markers AFP and SOX17, and the hematopoietic transcription factor RUNX1. These findings deepen the knowledge about the hematopoietic propensity of hPSCs and identify its variability as an aspect that must be taken into account before the usage of hPSC-derived HSCs in downstream applications.
Get full access to this article
View all access options for this article.
References
1.
AllegrucciC., and YoungL.E. (2007). Differences between human embryonic stem cell lines. Hum. Reprod. Update, 13, 103–120.
AntasV.I., Al-DreesM.A., PrudenceA.J., SugiyamaD., and FraserS.T. (2013). Hemogenic endothelium: a vessel for blood production. Int. J. Biochem. Cell Biol., 45, 692–695.
4.
BhattacharyaB., CaiJ., LuoY., MiuraT., MejidoJ., BrimbleS.N., ZengX., SchulzT.C., RaoM.S., and PuriR.K. (2005). Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev. Biol., 5, 22.
5.
CerdanC., McIntyreB.A., MechaelR., Levadoux-MartinM., YangJ., LeeJ.B., and BhatiaM. (2012). Activin A promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells. Stem Cells Dev. 21, 2866–2877.
6.
ChadwickK., WangL., LiL., MenendezP., MurdochB., RouleauA., and BhatiaM. (2003). Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood, 102, 906–915.
7.
ChangK.H., NelsonA.M., FieldsP.A., HessonJ.L., UlyanovaT., CaoH., NakamotoB., WareC.B., and PapayannopoulouT. (2008). Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp. Cell Res., 314, 2930–2940.
8.
ChenM.J., YokomizoT., ZeiglerB.M., DzierzakE., and SpeckN.A. (2009). Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature, 457, 887–891.
9.
ChichaL., FekiA., BoniA., IrionO., HovattaO., and JaconiM. (2011). Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34− and CD34+ progenitors with distinct characteristics. PLoS One, 6, e14733.
10.
ChoiK., KennedyM., KazarovA., PapadimitriouJ.C., and KellerG. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125, 725–732.
11.
ChoiK.D., YuJ., Smuga-OttoK., SalvagiottoG., RehrauerW., VodyanikM., ThomsonJ., and SlukvinI. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells, 27, 559–567.
12.
ConleyB.J., TrounsonA.O., and MollardR. (2004). Human embryonic stem cells form embryoid bodies containing visceral endoderm-like derivatives. Fetal Diagn. Ther., 19, 218–223.
13.
CortesJ.L., SanchezL., LigeroG., Gutierrez-ArandaI., CatalinaP., ElosuaC., LeoneP.E., MontesR., BuenoC., Ramos-MejíaV., MalenoI., García-PérezJ.L., and MenendezP. (2009). Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Hum. Reprod., 24, 1844–1851.
DvashT., MaysharY., DarrH., McElhaneyM., BarkerD., YanukaO., KotkowK.J., RubinL., BenvenistyN., and EigesR. (2004). Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum. Reprod., 19, 2875–2883.
16.
DvorakP., DvorakovaD., KoskovaS., VodinskaM., NajvirtovaM., KrekacD., and HamplA. (2005). Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem Cells, 23, 1200–1211.
17.
DzierzakE., and SpeckN.A. (2008). Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat. Immunol., 9, 129–136.
18.
EvseenkoD., ZhuY., Schenke-LaylandK., KuoJ., LatourB., GeS., ScholesJ., DravidG., LiX., MacLellanW.R., and CrooksG.M. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A., 107, 13742–13747.
19.
FerrellP.I., HexumM.K., KopherR.A., LepleyM.A., GussiaasA., and KaufmanD.S. (2014). Functional assessment of hematopoietic niche cells derived from human embryonic stem cells. Stem Cells Dev. 15, 1355–1363.
20.
GhoshZ., WilsonK.D., WuY., HuS., QuertermousT., and WuJ.C. (2010). Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One, 5, e8975.
21.
GinisI., LuoY., MiuraT., ThiesS., BrandenbergerR., Gerecht-NirS., AmitM., HokeA., CarpenterM.K., Itskovitz-EldorJ., and RaoM.S. (2004). Differences between human and mouse embryonic stem cells. Dev. Biol., 269, 360–380.
22.
HongS.H., Werbowetski-OgilvieT., Ramos-MejiaV., LeeJ.B., and BhatiaM. (2010). Multiparameter comparisons of embryoid body differentiation toward human stem cell applications. Stem Cell Res. 5, 120–130.
23.
JacksonS.A., SchiesserJ., StanleyE.G., and ElefantyA.G. (2010). Differentiating embryonic stem cells pass through ‘temporal windows’ that mark responsiveness to exogenous and paracrine mesendoderm inducing signals. PLoS One, 5, e10706.
24.
JiangW., ZhangD., BursacN., and ZhangY. (2013). WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs. Stem Cell Reports, 1, 46–52.
25.
KaufmanD.S., HansonE.T., LewisR.L., AuerbachR., and ThomsonJ.A. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A., 98, 10716–10721.
26.
KennedyM., AwongG., SturgeonC.M., DitadiA., LaMotte-MohsR., Zúñiga-PflückerJ.C., and KellerG. (2012). T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2, 1722–1735.
27.
KennedyM., D'SouzaS.L., Lynch-KattmanM., SchwantzS., and KellerG. (2007). Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood, 109, 2679–2687.
28.
KimJ.M., MoonS.H., LeeS.G., ChoY.J., HongK.S., LeeJ.H., LeeH.J., and ChungH.M. (2011a). Assessment of differentiation aspects by the morphological classification of embryoid bodies derived from human embryonic stem cells. Stem Cells Dev. 20, 1925–1935.
29.
KimK., ZhaoR., DoiA., NgK., UnternaehrerJ., CahanP., HuoH., LohY.H., AryeeM.J., LenschM.W., LiH., CollinsJ.J., FeinbergA.P., and DaleyG.Q. (2011b). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol., 29, 1117–1119.
30.
KunovaM., MatulkaK., EiselleovaL., SalykinA., KubikovaI., KyrylenkoS., HamplA., and DvorakP. (2013). Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability. Stem Cells Transl. Med., 2, 246–254.
31.
LaiM.I., Wendy-YeoW.Y., RamasamyR., NordinN., RosliR., VeerakumarasivamA., and AbdullahS. (2011). Advancements in reprogramming strategies for the generation of induced pluripotent stem cells. J. Assist. Reprod. Genet., 28, 291–301.
32.
LancrinC., SroczynskaP., StephensonC., AllenT., KouskoffV., and LacaudG. (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature, 457, 892–895.
33.
LaurentL.C., UlitskyI., SlavinI., TranH., SchorkA., MoreyR., LynchC., HarnessJ.V., LeeS., BarreroM.J., KuS., MartynovaM., SemechkinR., GalatV., GottesfeldJ., Izpisua BelmonteJ.C., MurryC., KeirsteadH.S., ParkH.S., SchmidtU., LaslettA.L., MullerF.J., NievergeltC.M., ShamirR., and LoringJ.F. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell, 8, 106–118.
34.
LedranM.H., KrassowskaA., ArmstrongL., DimmickI., RenströmJ., LangR., YungS., Santibanez-CorefM., DzierzakE., StojkovicM., OostendorpR.A., ForresterL., and LakoM. (2008). Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell, 3, 85–98.
35.
LengerkeC., GrauerM., NiebuhrN.I., RiedtT., KanzL., ParkI.H., and DaleyG.Q. (2009). Hematopoietic development from human induced pluripotent stem cells. Ann. N. Y. Acad. Sci., 1176, 219–227.
36.
LuM., KardelM.D., O'ConnorM.D., and EavesC.J. (2009). Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp. Hematol., 37, 924–936.
37.
MartíM., MuleroL., PardoC., MoreraC., CarrióM., Laricchia-RobbioL., EstebanC.R., and Izpisua BelmonteJ.C. (2013). Characterization of pluripotent stem cells. Nat. Protoc., 8, 223–253.
38.
MelicharH., LiO., RossJ., HaberH., CadoD., NollaH., RobeyE.A., and WinotoA. (2011). Comparative study of hematopoietic differentiation between human embryonic stem cell lines. PLoS One, 6, e19854.
Nakajima-TakagiY., OsawaM., OshimaM., TakagiH., MiyagiS., EndohM., EndoT.A., TakayamaN., EtoK., ToyodaT., KosekiH., NakauchiH., and IwamaA. (2013). Role of SOX17 in hematopoietic development from human embryonic stem cells. Blood, 121, 447–458.
41.
NgE.S., AzzolaL., SourrisK., RobbL., StanleyE.G., and ElefantyA.G. (2005). The primitive streak gene Mixl1 is required for efficient haematopoiesis and BMP4-induced ventral mesoderm patterning in differentiating ES cells. Development, 132, 873–884.
42.
NgE.S., DavisR., StanleyE.G., and ElefantyA.G. (2008). A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc., 3, 768–776.
43.
OsafuneK., CaronL., BorowiakM., MartinezR.J., Fitz-GeraldC.S., SatoY., CowanC.A., ChienK.R., and MeltonD.A. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol., 26, 313–315.
PickM., AzzolaL., MossmanA., StanleyE.G., and ElefantyA.G. (2007). Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells, 25, 2206–2214.
46.
Ramos-MejiaV., MelenG.J., SanchezL., Gutierrez-ArandaI., LigeroG., CortesJ.L., RealP.J., BuenoC., and MenendezP. (2010). Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol. Ther., 18, 2173–2181.
47.
RybtsovS., BatsivariA., BilotkachK., ParuzinaD., SenserrichJ., NerushevO., and MedvinskyA. (2014). Tracing the origin of the HSC hierarchy reveals an SCF-dependent, IL-3-independent CD43(-) embryonic precursor. Stem Cell Reports, 3, 489–501.
48.
SajiniA.A., GrederL.V., DuttonJ.R., and SlackJ.M. (2012). Loss of Oct4 expression during the development of murine embryoid bodies. Dev. Biol., 371, 170–179.
49.
SimaraP., TesarovaL., PadourovaS., and KoutnaI. (2014). Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods. Folia Biol. (Praha)., 60(Suppl. 1), 85–89.
50.
SturgeonC.M., DitadiA., AwongG., KennedyM., and KellerG. (2014). Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat. Biotechnol., 32, 554–561.
51.
SturgeonC.M., DitadiA., ClarkeR.L., and KellerG. (2013). Defining the path to hematopoietic stem cells. Nat. Biotechnol., 31, 416–418.
52.
SumiT., TsuneyoshiN., NakatsujiN., and SuemoriH. (2008). Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development, 135, 2969–2979.
53.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
54.
TesarovaL., SimaraP., StejskalS., and KoutnaI. (2014). Haematopoietic developmental potential of human pluripotent stem cell lines. Folia Biol. (Praha)., 60(Suppl. 1), 90–94.
55.
TesarovaL., SimaraP., StejskalS., and KoutnaI. (2016). The aberrant DNA methylation profile of human induced pluripotent stem cells is connected to the reprogramming process and is normalized during in vitro culture. PLoS One, 11, e0157974.
56.
ThomsonJ.A., Itskovitz-EldorJ., ShapiroS.S., WaknitzM.A., SwiergielJ.J., MarshallV.S., and JonesJ.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.
57.
VijayaragavanK., SzaboE., BosséM., Ramos-MejiaV., MoonR.T., and BhatiaM. (2009). Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell, 4, 248–262.
58.
VodyanikM.A., BorkJ.A., ThomsonJ.A., and SlukvinI.I. (2005). Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105, 617–626.
59.
WilsonJ.L., SuriS., SinghA., RivetC.A., LuH., and McDevittT.C. (2014). Single-cell analysis of embryoid body heterogeneity using microfluidic trapping array. Biomed. Microdevices, 16, 79–90.
60.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinI.I., and ThomsonJ.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
61.
ZambidisE.T., PeaultB., ParkT.S., BunzF., and CivinC.I. (2005). Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood, 106, 860–870.
62.
ZhangX., HuangC.T., ChenJ., PankratzM.T., XiJ., LiJ., YangY., LavauteT.M., LiX.J., AyalaM., BondarenkoG.I., DuZ.W., JinY., GolosT.G., and ZhangS.C. (2010). Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell, 7, 90–100.
